## Introduction

## Overview

In May 2024, the infectious disease landscape in Mainland China exhibited significant variations in disease prevalence, distribution, and associated mortality. The highest total number of cases were reported for Hand, Foot, and Mouth Disease (HFMD) with 193,230 cases but low associated mortality (2 deaths). This was followed by Hepatitis with 135,827 cases and a higher mortality rate of 53 deaths. Infectious diarrhea cases were also high at 127,630, with 3 deaths reported. Other considerable disease burdens were seen with Tuberculosis (84304 cases with 179 deaths) and Syphilis (54217 cases with 3 deaths). 

On the other hand, lower incidence diseases but notable in terms of mortality included Rabies, with 42 cases leading to a sizable 37 deaths, reflecting a high case-fatality rate. Other diseases such as Japanese Encephalitis and Neonatal Tetanus exhibited low case numbers but high morbidity, with 173 and 5 cases, respectively, and a mortality rate of three each.

## Concerns

Among diseases with high incidence, Hepatitis warrants particular attention. It constitutes a vast disease burden, with Hepatitis B (106985 cases, 40 deaths) and C (23334 cases, 13 deaths) being the most prevalent. Owing to its chronic nature and potential for severe liver disease, it poses a long-term public health challenge.

Public concern may not always align with epidemiological data. Diseases with high case-fatality rates, although relatively rare, often generate substantial apprehension. For instance, Rabies might not be a significant contributor to overall disease burden, but its high case-fatality rate can invoke disproportionate fear. Similarly, HFMD, despite its high incidence, does not lead to significant mortality, but it could cause considerable public concern given its potential to affect children significantly.

## Recommendations

Public health interventions should prioritize diseases with both high incidence and significant associated mortality. Efforts should be directed towards Hepatitis prevention, via enhanced vaccination programs, improving hygiene and sanitation, and providing safer blood and injection services. Addressing the disease burden posed by the high incidence of HFMD, Tuberculosis and Syphilis is critical. Public health campaigns focusing on hygiene for HFMD, early detection for Tuberculosis, and safe sexual practices for Syphilis could be beneficial. 

Nevertheless, not all strategies should be purely incidence-based. High case-fatality diseases like Rabies mustn't be overlooked. Community awareness initiatives about the importance of immediate medical care following suspected exposure, together with improved access to post-exposure prophylaxis, are essential. 

Lastly, effective public health communication is crucial. Facts must be transparent and easily understood, to dispel unnecessary fears and misconceptions. Diseases like HFMD, despite their high incidence, have low case-fatality rates and hence require balanced messaging to prevent undue panic. Conversely, low-incidence but high-case fatality diseases like Rabies, require urgent actions like seeking immediate medical care if exposed. 

In conclusion, a multi-pronged strategy, encompassing prevention, early detection and treatment, as well as effective health communication, is essential in controlling the varying disease burdens across Mainland China.


## Latest Update

Version: 2024 May

| Diseases                                                                     | Cases     | Comparison with 2024 April   | Comparison with 2023 May   | Deaths   | Comparison with 2024 April   | Comparison with 2023 May   |
|:-----------------------------------------------------------------------------|:----------|:-----------------------------|:---------------------------|:---------|:-----------------------------|:---------------------------|
| [Plague](./Plague)                                                           | 0         | 0 (/)                        | 0.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Cholera](./Cholera)                                                         | 0         | 0 (/)                        | -3.0 (-100.00%)            | 0        | 0 (/)                        | 0.0 (/)                    |
| [SARS-CoV](./SARS-CoV)                                                       | 0         | 0 (/)                        | 0.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Acquired immune deficiency syndrome](./Acquired-immune-deficiency-syndrome) | 4,987     | -370 (-6.91%)                | -468.0 (-8.58%)            | 1,611    | -107 (-6.23%)                | -322.0 (-16.66%)           |
| [Hepatitis](./Hepatitis)                                                     | 165,333   | -2,942 (-1.75%)              | 23,841.0 (16.85%)          | 195      | -36 (-15.58%)                | 25.0 (14.71%)              |
| [Hepatitis A](./Hepatitis-A)                                                 | 1,419     | -205 (-12.62%)               | 343.0 (31.88%)             | 0        | 0 (/)                        | 0.0 (/)                    |
| [Hepatitis B](./Hepatitis-B)                                                 | 139,523   | -1,041 (-0.74%)              | 23,589.0 (20.35%)          | 20       | -1 (-4.76%)                  | 3.0 (17.65%)               |
| [Hepatitis C](./Hepatitis-C)                                                 | 20,462    | -1,443 (-6.59%)              | -501.0 (-2.39%)            | 174      | -35 (-16.75%)                | 23.0 (15.23%)              |
| [Hepatitis D](./Hepatitis-D)                                                 | 15        | -2 (-11.76%)                 | -5.0 (-25.00%)             | 0        | 0 (/)                        | 0.0 (/)                    |
| [Hepatitis E](./Hepatitis-E)                                                 | 3,310     | -283 (-7.88%)                | 488.0 (17.29%)             | 1        | 0 (0.00%)                    | -1.0 (-50.00%)             |
| [Other hepatitis](./Other-hepatitis)                                         | 604       | 32 (5.59%)                   | -73.0 (-10.78%)            | 0        | 0 (/)                        | 0.0 (/)                    |
| [Poliomyelitis](./Poliomyelitis)                                             | 0         | 0 (/)                        | 0.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Human infection with H5N1 virus](./Human-infection-with-H5N1-virus)         | 0         | 0 (/)                        | 0.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Measles](./Measles)                                                         | 162       | 14 (9.46%)                   | 53.0 (48.62%)              | 0        | 0 (/)                        | 0.0 (/)                    |
| [Epidemic hemorrhagic fever](./Epidemic-hemorrhagic-fever)                   | 359       | 59 (19.67%)                  | -40.0 (-10.03%)            | 2        | 1 (100.00%)                  | 2.0 (/)                    |
| [Rabies](./Rabies)                                                           | 13        | 4 (44.44%)                   | 3.0 (30.00%)               | 10       | 2 (25.00%)                   | 3.0 (42.86%)               |
| [Japanese encephalitis](./Japanese-encephalitis)                             | 3         | 2 (200.00%)                  | 3.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Dengue](./Dengue)                                                           | 109       | 51 (87.93%)                  | 88.0 (419.05%)             | 0        | 0 (/)                        | 0.0 (/)                    |
| [Anthrax](./Anthrax)                                                         | 21        | 1 (5.00%)                    | -4.0 (-16.00%)             | 1        | 1 (/)                        | 1.0 (/)                    |
| [Dysentery](./Dysentery)                                                     | 3,408     | 886 (35.13%)                 | -345.0 (-9.19%)            | 0        | 0 (/)                        | 0.0 (/)                    |
| [Tuberculosis](./Tuberculosis)                                               | 63,595    | -5,137 (-7.47%)              | -5,473.0 (-7.92%)          | 251      | -68 (-21.32%)                | -92.0 (-26.82%)            |
| [Typhoid fever and paratyphoid fever](./Typhoid-fever-and-paratyphoid-fever) | 418       | 64 (18.08%)                  | -129.0 (-23.58%)           | 0        | 0 (/)                        | 0.0 (/)                    |
| [Meningococcal meningitis](./Meningococcal-meningitis)                       | 12        | -3 (-20.00%)                 | 10.0 (500.00%)             | 0        | 0 (/)                        | 0.0 (/)                    |
| [Pertussis](./Pertussis)                                                     | 97,669    | 6,397 (7.01%)                | 96,335.0 (7221.51%)        | 2        | -5 (-71.43%)                 | 2.0 (/)                    |
| [Diphtheria](./Diphtheria)                                                   | 0         | 0 (/)                        | 0.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Neonatal tetanus](./Neonatal-tetanus)                                       | 2         | 2 (/)                        | 2.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Scarlet fever](./Scarlet-fever)                                             | 10,271    | 4,146 (67.69%)               | 8,373.0 (441.15%)          | 0        | 0 (/)                        | 0.0 (/)                    |
| [Brucellosis](./Brucellosis)                                                 | 8,007     | 866 (12.13%)                 | -1,060.0 (-11.69%)         | 1        | 0 (0.00%)                    | 1.0 (/)                    |
| [Gonorrhea](./Gonorrhea)                                                     | 8,611     | 473 (5.81%)                  | -466.0 (-5.13%)            | 0        | 0 (/)                        | 0.0 (/)                    |
| [Syphilis](./Syphilis)                                                       | 60,962    | -549 (-0.89%)                | 7,704.0 (14.47%)           | 7        | 3 (75.00%)                   | -3.0 (-30.00%)             |
| [Leptospirosis](./Leptospirosis)                                             | 22        | 15 (214.29%)                 | 14.0 (175.00%)             | 0        | 0 (/)                        | 0.0 (/)                    |
| [Schistosomiasis](./Schistosomiasis)                                         | 3         | 1 (50.00%)                   | 0.0 (0.00%)                | 0        | 0 (/)                        | 0.0 (/)                    |
| [Malaria](./Malaria)                                                         | 236       | 46 (24.21%)                  | 24.0 (11.32%)              | 0        | -1 (-100.00%)                | 0.0 (/)                    |
| [Human infection with H7N9 virus](./Human-infection-with-H7N9-virus)         | 0         | 0 (/)                        | 0.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Influenza](./Influenza)                                                     | 440,431   | -1,280 (-0.29%)              | 227,542.0 (106.88%)        | 4        | 4 (/)                        | 2.0 (100.00%)              |
| [Mumps](./Mumps)                                                             | 10,197    | 942 (10.18%)                 | 1,267.0 (14.19%)           | 0        | 0 (/)                        | 0.0 (/)                    |
| [Rubella](./Rubella)                                                         | 82        | 14 (20.59%)                  | 9.0 (12.33%)               | 0        | 0 (/)                        | 0.0 (/)                    |
| [Acute hemorrhagic conjunctivitis](./Acute-hemorrhagic-conjunctivitis)       | 2,920     | 117 (4.17%)                  | 609.0 (26.35%)             | 0        | 0 (/)                        | 0.0 (/)                    |
| [Leprosy](./Leprosy)                                                         | 31        | -12 (-27.91%)                | 4.0 (14.81%)               | 0        | 0 (/)                        | 0.0 (/)                    |
| [Typhus](./Typhus)                                                           | 190       | 37 (24.18%)                  | 19.0 (11.11%)              | 0        | 0 (/)                        | 0.0 (/)                    |
| [Kala azar](./Kala-azar)                                                     | 27        | -6 (-18.18%)                 | -5.0 (-15.62%)             | 0        | 0 (/)                        | 0.0 (/)                    |
| [Echinococcosis](./Echinococcosis)                                           | 380       | -105 (-21.65%)               | 66.0 (21.02%)              | 0        | 0 (/)                        | 0.0 (/)                    |
| [Filariasis](./Filariasis)                                                   | 0         | 0 (/)                        | 0.0 (/)                    | 0        | 0 (/)                        | 0.0 (/)                    |
| [Infectious diarrhea](./Infectious-diarrhea)                                 | 122,593   | -20,696 (-14.44%)            | 6,695.0 (5.78%)            | 0        | 0 (/)                        | 0.0 (/)                    |
| [Hand foot and mouth disease](./Hand-foot-and-mouth-disease)                 | 226,183   | 123,979 (121.31%)            | 134,924.0 (147.85%)        | 0        | 0 (/)                        | 0.0 (/)                    |
| [Monkey pox](./Monkey-pox)                                                   | 49        | 10 (25.64%)                  | / (/)                      | 0        | 0 (/)                        | / (/)                      |
| [Total](./Total)                                                             | 1,227,286 | 107,026 (9.55%)              | 499,641.0 (68.67%)         | 2,084    | -206 (-9.00%)                | -381.0 (-15.46%)           |

## Source Data

<a href=https://github.com/xmusphlkg/globalID/tree/main/Data/AllData/CN><i class="fab fa-github"></i> Github</a>